 |
PDBsum entry 2qc9
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
2qc9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
282:24027-24038
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor.
|
|
M.L.Coleman,
M.A.McDonough,
K.S.Hewitson,
C.Coles,
J.Mecinovic,
M.Edelmann,
K.M.Cook,
M.E.Cockman,
D.E.Lancaster,
B.M.Kessler,
N.J.Oldham,
P.J.Ratcliffe,
C.J.Schofield.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The stability and activity of hypoxia-inducible factor (HIF) are regulated by
the post-translational hydroxylation of specific prolyl and asparaginyl
residues. We show that the HIF asparaginyl hydroxylase, factor inhibiting HIF
(FIH), also catalyzes hydroxylation of highly conserved asparaginyl residues
within ankyrin repeat (AR) domains (ARDs) of endogenous Notch receptors. AR
hydroxylation decreases the extent of ARD binding to FIH while not affecting
signaling through the canonical Notch pathway. ARD proteins were found to
efficiently compete with HIF for FIH-dependent hydroxylation. Crystallographic
analyses of the hydroxylated Notch ARD (2.35A) and of Notch peptides bound to
FIH (2.4-2.6A) reveal the stereochemistry of hydroxylation on the AR and imply
that significant conformational changes are required in the ARD fold in order to
enable hydroxylation at the FIH active site. We propose that ARD proteins
function as natural inhibitors of FIH and that the hydroxylation status of these
proteins provides another oxygen-dependent interface that modulates HIF
signaling.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Structure of Asn-hydroxylated N1 ARD.A, stereoview ribbon
representation from the 2.35 Å resolution crystal
structure of N1 ARD (OH); six ARs (numbered 2–7) are observed
in the N1 ARD (OH) structure. The hydroxylated Asn-1945 (AR 2)
and unhydroxylated Asn-2012 (AR 4) are yellow ball-and-stick
representations. B, stereoview of electron density around
Asn-1945 showing the pro-S configuration of the hydroxylated
Asn-1945 β-carbon. 2F[o] - F[c] map (cyan mesh) contoured to
1σ and an F[o] - F[c] OMIT map (dark blue mesh) contoured to
5σ (produced by omitting the hydroxyl group from the
calculation). This region of the β-hairpin loop has a type I
β-turn (Asp-1943, Ala-1944, Asn-1945, and Ile-1946 at the i, i
+ 1, i + 2, and i + 3 positions, respectively). Asn-1945 makes
three hydrogen bonds (dashed black lines); the nitrogen and
oxygen of the side chain amide form hydrogen bonds to the
backbone carbonyl oxygen of Ala-1975 and NH of Asp-1977, and the
β-hydroxy group hydrogen bonds with an Asp-1943 carboxylate
oxygen. C, ribbon representation of the Asn-1945 hydroxylated
mN1-(1898–2105) (blue) and the MAML-1 (green)·human
N1-(1873–2127) (purple)·CSL
(yellow/beige/orange)·DNA (blue) complex (Protein Data
Bank code 2F8X) structures (24) superimposed.
|
 |
Figure 6.
Notch-FIH interactions.A, the FIH homodimer (molecule A
(pink) and molecule B (green)) in complex with N1-(1930–1949)
(yellow ball-and-stick representation bound to A, blue bound to
B) with the double-stranded β-helix core (blue in A and
raspberry in B) and Fe(II) (orange sphere). B, stereoview ribbon
representation of the
FIH·Fe(II)·2OG·N1-(1930–1949) dimer
structure complexed with the N1 peptide to 2.4 Å
resolution in yellow ball-and-stick representation and the σ[A]
weighted composite OMIT mF[o] - DF[c] difference electron
density contoured to 3σ (blue mesh) created by omitting the
Notch1 atoms from the calculation. Electron density was apparent
for residues 1936–1945 of the N1-(1930–1949) peptide (close
up view; supplemental Fig. S3). C, the FIH active site (FIH
(salmon with residues in white ball-and-stick representation),
2OG (green), N1-(1930–1949) (yellow), and Fe(II) (orange
sphere)). The pro-S C–H bond (gray) modeled at the Cβ
position of N1 Asn-1945 is positioned for oxidation. D,
ball-and-stick representation of the superimposed peptides when
bound to FIH. yellow, N1-(1930–1949); cyan, N1-(1997–2016);
white, HIF1αCAD. E, close up of superimposed structures:
FIH·N1-(1930–1949) (yellow),
FIH·N1-(1997–2016) (cyan), and FIH·HIF1αCAD
(white) showing the binding of the conserved leucine (N1
Leu-1937/2004 and HIF1αCAD Leu-795) in a hydrophobic pocket
(yellow-green surface) formed by residues from molecules A (dark
green) and B(orange) of the FIH dimer. F, superimposition of the
target Asn of N1-(1930–1949) when bound to FIH and the
equivalent Asn in the N1 ARD structure emphasizes the
conformational changes between them.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2007,
282,
24027-24038)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Yan,
M.Kong,
and
Y.H.Chen
(2011).
Prevention of apoptosis by the interaction between FIH1 and Bax.
|
| |
Mol Cell Biochem,
348,
1-9.
|
 |
|
|
|
|
 |
C.Loenarz,
and
C.J.Schofield
(2011).
Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases.
|
| |
Trends Biochem Sci,
36,
7.
|
 |
|
|
|
|
 |
E.Muchnik,
and
J.Kaplan
(2011).
HIF prolyl hydroxylase inhibitors for anemia.
|
| |
Expert Opin Investig Drugs,
20,
645-656.
|
 |
|
|
|
|
 |
M.N.Khan,
T.Bhattacharyya,
P.Andrikopoulos,
M.A.Esteban,
R.Barod,
T.Connor,
M.Ashcroft,
P.H.Maxwell,
and
S.Kiriakidis
(2011).
Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis.
|
| |
Br J Cancer,
104,
1151-1159.
|
 |
|
|
|
|
 |
M.Yang,
R.Chowdhury,
W.Ge,
R.B.Hamed,
M.A.McDonough,
T.D.Claridge,
B.M.Kessler,
M.E.Cockman,
P.J.Ratcliffe,
and
C.J.Schofield
(2011).
Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.
|
| |
FEBS J,
278,
1086-1097.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Yang,
W.Ge,
R.Chowdhury,
T.D.Claridge,
H.B.Kramer,
B.Schmierer,
M.A.McDonough,
L.Gong,
B.M.Kessler,
P.J.Ratcliffe,
M.L.Coleman,
and
C.J.Schofield
(2011).
Asparagine and Aspartate Hydroxylation of the Cytoskeletal Ankyrin Family Is Catalyzed by Factor-inhibiting Hypoxia-inducible Factor.
|
| |
J Biol Chem,
286,
7648-7660.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Schmierer,
B.Novák,
and
C.J.Schofield
(2010).
Hypoxia-dependent sequestration of an oxygen sensor by a widespread structural motif can shape the hypoxic response--a predictive kinetic model.
|
| |
BMC Syst Biol,
4,
139.
|
 |
|
|
|
|
 |
C.Loenarz,
W.Ge,
M.L.Coleman,
N.R.Rose,
C.D.Cooper,
R.J.Klose,
P.J.Ratcliffe,
and
C.J.Schofield
(2010).
PHF8, a gene associated with cleft lip/palate and mental retardation, encodes for an Nepsilon-dimethyl lysine demethylase.
|
| |
Hum Mol Genet,
19,
217-222.
|
 |
|
|
|
|
 |
E.Flashman,
S.L.Davies,
K.K.Yeoh,
and
C.J.Schofield
(2010).
Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
|
| |
Biochem J,
427,
135-142.
|
 |
|
|
|
|
 |
G.Czibik
(2010).
Complex role of the HIF system in cardiovascular biology.
|
| |
J Mol Med,
88,
1101-1111.
|
 |
|
|
|
|
 |
J.Cantley,
S.T.Grey,
P.H.Maxwell,
and
D.J.Withers
(2010).
The hypoxia response pathway and β-cell function.
|
| |
Diabetes Obes Metab,
12,
159-167.
|
 |
|
|
|
|
 |
J.Schödel,
D.Bohr,
B.Klanke,
G.Schley,
U.Schlötzer-Schrehardt,
C.Warnecke,
A.Kurtz,
K.Amann,
K.U.Eckardt,
and
C.Willam
(2010).
Factor inhibiting HIF limits the expression of hypoxia-inducible genes in podocytes and distal tubular cells.
|
| |
Kidney Int,
78,
857-867.
|
 |
|
|
|
|
 |
J.T.Yustein,
Y.C.Liu,
P.Gao,
C.Jie,
A.Le,
M.Vuica-Ross,
W.J.Chng,
C.G.Eberhart,
P.L.Bergsagel,
and
C.V.Dang
(2010).
Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model.
|
| |
Proc Natl Acad Sci U S A,
107,
3534-3539.
|
 |
|
|
|
|
 |
N.Zhang,
Z.Fu,
S.Linke,
J.Chicher,
J.J.Gorman,
D.Visk,
G.G.Haddad,
L.Poellinger,
D.J.Peet,
F.Powell,
and
R.S.Johnson
(2010).
The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism.
|
| |
Cell Metab,
11,
364-378.
|
 |
|
|
|
|
 |
S.Nagel,
N.P.Talbot,
J.Mecinović,
T.G.Smith,
A.M.Buchan,
and
C.J.Schofield
(2010).
Therapeutic manipulation of the HIF hydroxylases.
|
| |
Antioxid Redox Signal,
12,
481-501.
|
 |
|
|
|
|
 |
S.P.Colgan,
and
C.T.Taylor
(2010).
Hypoxia: an alarm signal during intestinal inflammation.
|
| |
Nat Rev Gastroenterol Hepatol,
7,
281-287.
|
 |
|
|
|
|
 |
T.Jokilehto,
and
P.M.Jaakkola
(2010).
The role of HIF prolyl hydroxylases in tumour growth.
|
| |
J Cell Mol Med,
14,
758-770.
|
 |
|
|
|
|
 |
A.Al Haj Zen,
and
P.Madeddu
(2009).
Notch signalling in ischaemia-induced angiogenesis.
|
| |
Biochem Soc Trans,
37,
1221-1227.
|
 |
|
|
|
|
 |
D.Barrick
(2009).
Biological regulation via ankyrin repeat folding.
|
| |
ACS Chem Biol,
4,
19-22.
|
 |
|
|
|
|
 |
D.H.Shin,
S.H.Li,
S.W.Yang,
B.L.Lee,
M.K.Lee,
and
J.W.Park
(2009).
Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha.
|
| |
FEBS J,
276,
3470-3480.
|
 |
|
|
|
|
 |
D.Locke,
S.Bian,
H.Li,
and
A.L.Harris
(2009).
Post-translational modifications of connexin26 revealed by mass spectrometry.
|
| |
Biochem J,
424,
385-398.
|
 |
|
|
|
|
 |
J.D.Webb,
A.Murányi,
C.W.Pugh,
P.J.Ratcliffe,
and
M.L.Coleman
(2009).
MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH).
|
| |
Biochem J,
420,
327-333.
|
 |
|
|
|
|
 |
J.M.Gleadle
(2009).
Review article: How cells sense oxygen: lessons from and for the kidney.
|
| |
Nephrology (Carlton),
14,
86-93.
|
 |
|
|
|
|
 |
K.Balamurugan,
V.D.Luu,
M.R.Kaufmann,
V.S.Hofmann,
G.Boysen,
S.Barth,
M.R.Bordoli,
D.P.Stiehl,
H.Moch,
P.Schraml,
R.H.Wenger,
and
G.Camenisch
(2009).
Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
|
| |
Oncogene,
28,
3274-3285.
|
 |
|
|
|
|
 |
K.De Bock,
F.De Smet,
R.Leite De Oliveira,
K.Anthonis,
and
P.Carmeliet
(2009).
Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells.
|
| |
J Mol Med,
87,
561-569.
|
 |
|
|
|
|
 |
K.M.Cook,
S.T.Hilton,
J.Mecinovic,
W.B.Motherwell,
W.D.Figg,
and
C.J.Schofield
(2009).
Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.
|
| |
J Biol Chem,
284,
26831-26838.
|
 |
|
|
|
|
 |
K.M.Oliver,
C.T.Taylor,
and
E.P.Cummins
(2009).
Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases.
|
| |
Arthritis Res Ther,
11,
215.
|
 |
|
|
|
|
 |
K.Nakayama,
J.Qi,
and
Z.Ronai
(2009).
The ubiquitin ligase Siah2 and the hypoxia response.
|
| |
Mol Cancer Res,
7,
443-451.
|
 |
|
|
|
|
 |
L.Kelly,
M.A.McDonough,
M.L.Coleman,
P.J.Ratcliffe,
and
C.J.Schofield
(2009).
Asparagine beta-hydroxylation stabilizes the ankyrin repeat domain fold.
|
| |
Mol Biosyst,
5,
52-58.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.E.Cockman,
J.D.Webb,
H.B.Kramer,
B.M.Kessler,
and
P.J.Ratcliffe
(2009).
Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
|
| |
Mol Cell Proteomics,
8,
535-546.
|
 |
|
|
|
|
 |
M.E.Cockman,
J.D.Webb,
and
P.J.Ratcliffe
(2009).
FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
|
| |
Ann N Y Acad Sci,
1177,
9.
|
 |
|
|
|
|
 |
S.E.Wilkins,
J.Hyvärinen,
J.Chicher,
J.J.Gorman,
D.J.Peet,
R.L.Bilton,
and
P.Koivunen
(2009).
Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1).
|
| |
Int J Biochem Cell Biol,
41,
1563-1571.
|
 |
|
|
|
|
 |
T.O.Street,
and
D.Barrick
(2009).
Predicting repeat protein folding kinetics from an experimentally determined folding energy landscape.
|
| |
Protein Sci,
18,
58-68.
|
 |
|
|
|
|
 |
T.Sakamoto,
and
M.Seiki
(2009).
Mint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1.
|
| |
J Biol Chem,
284,
30350-30359.
|
 |
|
|
|
|
 |
U.Lendahl,
K.L.Lee,
H.Yang,
and
L.Poellinger
(2009).
Generating specificity and diversity in the transcriptional response to hypoxia.
|
| |
Nat Rev Genet,
10,
821-832.
|
 |
|
|
|
|
 |
W.M.Bernhardt,
U.Gottmann,
F.Doyon,
B.Buchholz,
V.Campean,
J.Schödel,
A.Reisenbuechler,
S.Klaus,
M.Arend,
L.Flippin,
C.Willam,
M.S.Wiesener,
B.Yard,
C.Warnecke,
and
K.U.Eckardt
(2009).
Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model.
|
| |
Proc Natl Acad Sci U S A,
106,
21276-21281.
|
 |
|
|
|
|
 |
C.Loenarz,
and
C.J.Schofield
(2008).
Expanding chemical biology of 2-oxoglutarate oxygenases.
|
| |
Nat Chem Biol,
4,
152-156.
|
 |
|
|
|
|
 |
H.Zhang,
and
G.L.Semenza
(2008).
The expanding universe of hypoxia.
|
| |
J Mol Med,
86,
739-746.
|
 |
|
|
|
|
 |
K.Lisy,
and
D.J.Peet
(2008).
Turn me on: regulating HIF transcriptional activity.
|
| |
Cell Death Differ,
15,
642-649.
|
 |
|
|
|
|
 |
L.Poellinger,
and
U.Lendahl
(2008).
Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms.
|
| |
Curr Opin Genet Dev,
18,
449-454.
|
 |
|
|
|
|
 |
R.Chowdhury,
A.Hardy,
and
C.J.Schofield
(2008).
The human oxygen sensing machinery and its manipulation.
|
| |
Chem Soc Rev,
37,
1308-1319.
|
 |
|
|
|
|
 |
W.G.Kaelin,
and
P.J.Ratcliffe
(2008).
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
|
| |
Mol Cell,
30,
393-402.
|
 |
|
|
|
|
 |
W.R.Gordon,
K.L.Arnett,
and
S.C.Blacklow
(2008).
The molecular logic of Notch signaling--a structural and biochemical perspective.
|
| |
J Cell Sci,
121,
3109-3119.
|
 |
|
|
|
|
 |
X.Zheng,
S.Linke,
J.M.Dias,
X.Zheng,
K.Gradin,
T.P.Wallis,
B.R.Hamilton,
M.Gustafsson,
J.L.Ruas,
S.Wilkins,
R.L.Bilton,
K.Brismar,
M.L.Whitelaw,
T.Pereira,
J.J.Gorman,
J.Ericson,
D.J.Peet,
U.Lendahl,
and
L.Poellinger
(2008).
Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways.
|
| |
Proc Natl Acad Sci U S A,
105,
3368-3373.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |